Since 2010, Inkef has backed more than 25 companies in healthcare and technology. We have supported and continue to actively support companies with financing, business strategy, insights and shaping their future.
Castor is a medical software development company based in Amsterdam, the Netherlands. Founded in 2011 by Derk Arts, their signature programme is a cloud-based electronic data capture platform which enables researchers to easily capture high-quality, reusable medical data. Now with 30k+ users, 2,500+ studies, servers in 3 countries and funding by INKEF Capital, Castor is well on their way to getting their platform used by medical researchers and institutions worldwide.View this case
Withlocals is an online marketplace for travelers and locals to connect. The platform lets locals create personal and unique travel experiences for travelers, earn their fair share by doing what they love, and gives travelers authentic experiences and stories to share with their friends and families. All this while changing minds and hearts along the way.View this case
Bloomon, is a subscription-based flower delivery service based in Amsterdam, was founded in 2014 by Patrick Hurenkamp and Koen Thijssen. Dubbed as the ‘Netflix of Flowers’ by the Financial Times, Bloomon’s goal is to bring bespoke bouquets from grower to consumer in the fastest way possible by cutting out the traditional supply chain. Headquartered in Amsterdam, it now has international offices in Berlin, London and Taiwan.View this case
ViCentra has developed an insulin pump for diabetes patients. The company aims to create a user-friendly device designed to provide diabetes patients with greater freedom in their day-to-day lives.
To create break through businesses in technology and healthcare.
Aside from the core investment team, INKEF leverages a network of global industry experts. They are thought leaders in their fields and, sometimes, they can even predict the future better than we can. They make us smarter, and we hope they can help you too. We also foster open dialogue between our portfolio companies so that the entrepreneurs we back can exchange learnings and avoid common pitfalls.